A risk model for severe anemia to select cancer patients for primary prophylaxis with epoetin alpha: a prospective randomized controlled trial of the ELYPSE study group.

Source:http://linkedlifedata.com/resource/pubmed/id/19174452

Download in:

View as

General Info

PMID
19174452